AzTrials
AzTrials

EndometriosisT-ENDONCT07907848

Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy

A study testing Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) in people with Endometriosis and Adenomyosis, run by Fiammetta Cosci at 1 site in Italy.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of the present study is to compare two types of psychotherapeutic interventions in women with endometriosis and/or adenomyosis: cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT). Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Endometriosis, Adenomyosis
What is being tested?
Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteItaly
Study dates
1 Jan 2027to 31 Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years;
  • Access to internet and having an email address;
  • Diagnosis of endometriosis and/or adenomyosis based on gynecological assessment and imaging evaluation, in accordance with ICD-11 classification (WHO, 2019);
  • Seeking care at the Endometriosis Center (Department of Obstetrics and Gynecology at Careggi University Hospital (AOUC));
  • Ability to provide informed consent;
  • Fluency in written and spoken Italian;
Show all 9Show fewer
  • Under stable pharmacological treatment for at least 3 months;
  • For Study 1: ≤12 months from diagnosis;
  • For Study 2: >12 months from diagnosis.

Who cannot join

  • Current psychiatric diagnosis assessed with the Structured Clinical Interview for DSM-5 (SCID-5; First et al., 2016);
  • Ongoing psychotherapeutic treatment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Fiammetta Cosci contact

0552755066

fiammetta.cosci@unifi.it

Italy1 site
  • Endometriosis Center, Department of Obstetrics and Gynecology, Careggi University Hospital (AOUC)

    Florence, FI, 50134

    Silvia Vannuccini, 055 794 7150, silvia.vannuccini@unifi.it

Other trials in Italy

About this study

Official title: Testing Efficacy of Psychotherapeutic Interventions in Patients With ENDOmetriosis: A Randomized Controlled Trial Comparing Cognitive Behavioral Therapy vs Acceptance and Commitment Therapy

The aim of the present study is to compare two types of psychotherapeutic interventions in women with endometriosis and/or adenomyosis: cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT). The study will examine whether these therapies differ in their effects on health-related quality of life. We hypothesis a different effect on health related quality of life pain-related difficulties, emotional well-being, fatigue, sexual functioning, and other aspects of daily life since the two interventions aim at different purposes and results. CBT is based on restructuring of thought, thus the aim and the result are activating a change. ACT is aimed at increasing acceptance of the existing condition in order to cope better with it. The literature indeed suggested that the two approach can produce different effects in the same clinical population.

The study will include women with a recent diagnosis and women who have been living with the diagnosis for a longer time.

Read more

Participants will be randomly assigned to receive either CBT or ACT. Both groups will attend eight therapy sessions, held every two weeks. Participants will complete online questionnaires before treatment, after session 4, after treatment, and 3 and 6 months after treatment. The questionnaires will assess quality of life, pain, emotional well-being, and other aspects of health and daily functioning.

The study will take place at the Endometriosis Centre of Careggi University Hospital in Florence, Italy. Eligible participants must be women aged 18 or older who are receiving care at this centre and have a confirmed diagnosis of endometriosis and/or adenomyosis based on medical assessment. They must have been on stable medication treatment for at least 3 months, speak and write Italian fluently, have internet access, and be able to provide informed consent. Women with a current psychiatric diagnosis or who are currently receiving psychotherapy are not eligible to participate in the study.

Read the detailed description

Endometriosis (ENDO) is a chronic inflammatory disease affecting 4-18% of women with symptoms such as dyspareunia, dysmenorrhea, dyschezia, low back pain, chronic pelvic pain and gastrointestinal manifestations. Meta-analyses showed higher anxiety, depression, and poorer quality of life in women with ENDO compared to healthy controls. Cross-sectional studies suggested that a psychological burden linked to pain and factors such as pain catastrophizing, low pain acceptance, self-criticism, psychological inflexibility (PI), maladaptive coping strategies, sexual dysfunction, maladaptive illness perceptions, early life adversity, negative body image, fatigue and low psychological flexibility. Long-term exposure to ENDO has been associated with an increased risk of developing more severe psychological distress over time. Therefore, accounting for time since diagnosis appears important when examining psychological outcomes in this population.

Psychological interventions such as psychoeducation, mindfulness-based techniques, acceptance and commitment therapy (ACT), and cognitive behavioral therapy (CBT) have shown promising results in improving pain, quality of life, anxiety, and depression in ENDO. However, this literature is sparse, and the methods used are heterogeneous. Furthermore, in these studies only pain, anxiety, depression, and quality of life have been investigated as outcomes measures although evidence from studies on other chronic illnesses and chronic pain conditions suggests that CBT and ACT interventions could also provide benefits in addressing self-criticism, eating-related psychopathology, psychological flexibility, maladaptive coping strategies, sexual dysfunction, maladaptive illness perceptions, fatigue, early life adversity, and negative body image. Furthermore, no studies to date have directly compared ACT-based and CBT-based interventions in women with ENDO. Given their different theoretical models and therapeutic targets, comparing the two interventions may help clarify their potential role in improving psychological adjustment and quality of life in ENDO.

Overall, studying the potential benefits of psychotherapeutic interventions based on CBT versus ACT components using rigorous methods, while accounting for illness duration, may help shed light on complementary therapeutic options for women with ENDO and on ways to modify their psychological burden trajectories, while also extending current knowledge by broadening the range of psychological outcomes assessed beyond commonly studied indicators such as pain, emotional distress, and quality of life.

The aim of the present study is to compare the effects of CBT-based versus ACT-based psychotherapeutic interventions on health-related quality of life in women with endometriosis and/or adenomyosis, considering both women with a recent diagnosis (≤12 months from diagnosis; Study 1) and those with a long-lasting diagnosis (>12 months from diagnosis; Study 2). This operational definition of "long-lasting" conditions is consistent with the literature on chronic illness adaptation, which conceptualizes the first year post-diagnosis as an early adjustment phase, whereas persistence beyond this period reflects a more established chronic illness trajectory and stabilized adaptation processes.

The study will also investigate the effects of the two interventions on a broad range of secondary outcomes in both Study 1 and Study 2, including endometriosis-specific quality of life, pain-related disability, psychological distress, psychological flexibility and related processes, coping strategies and emotion regulation, illness-related attitudes and perceptions, sexual functioning, life satisfaction, psychological well-being, and other clinical and psychological dimensions.

Being tested
Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT)
Keywords
Endometriosis, Adenomyosis, Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, Health-Related Quality of Life, Psychotherapeutic Intervention
Medical subject headings
Endometriosis, Adenomyosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavioral Therapy (CBT)Behavioural

    Cognitive behavioral therapy (CBT) delivered over 8 biweekly sessions, including psychoeducation, cognitive restructuring, behavioral strategies, and homework assignments. The intervention addresses physical pain, mental pain and psychological distress, relational and functional difficulties, and maladaptive cognitions. The session structure differs between Study 1 and Study 2.

  • Acceptance and Commitment Therapy (ACT)Behavioural

    Acceptance and commitment therapy (ACT) delivered over 8 biweekly sessions, including psychoeducation, experiential techniques, values-based action, and behavioral practice. The intervention addresses physical pain, mental pain and psychological distress, relational and functional difficulties, and maladaptive cognitions, while promoting psychological flexibility. The session structure differs between Study 1 and Study 2.

Study groups in NCT07907848
Study groupRoleWhat they receive
Cognitive Behavioral Therapy (CBT)ExperimentalCBT is a structured intervention targeting dysfunctional thoughts, emotions, and behaviors through psychoeducation, cognitive restructuring, behavioral strategies, and homework. As no standardized CBT protocol for endometriosis exists, this intervention was developed for this study based on CBT principles. In Study 1, CBT comprises 8 biweekly sessions (4 psychoeducational and 4 CBT sessions) targeting physical pain (including central sensitization), mental pain and distress, relational and functional difficulties (including dyspareunia and fatigue), and maladaptive cognitions (catastrophizing, hopelessness, helplessness, and perfectionism). In Study 2, CBT comprises 8 biweekly sessions: 4 core sessions addressing physical pain and dysfunctional thinking, mental pain and distress, relational and functional difficulties (including fatigue), and maladaptive cognitions. Each is followed by a consolidation session to review content and reinforce skills through behavioral exercises.
Receives: Behavioral: Cognitive Behavioral Therapy (CBT)
Acceptance and Commitment Therapy (ACT)Active comparatorACT promotes psychological flexibility and functioning despite distress through psychoeducation, experiential techniques, values-based action, and practice. As no standardized ACT protocol for endometriosis exists, this intervention was developed for this study based on ACT principles. In Study 1, ACT comprises 8 biweekly sessions (4 psychoeducational, 4 ACT) targeting physical pain (including central sensitization), mental pain and distress, relational and functional difficulties (including dyspareunia and fatigue), and maladaptive cognitions (catastrophizing, hopelessness, helplessness, perfectionism). In Study 2, ACT comprises 8 biweekly sessions: 4 core sessions address physical pain and an open response style, mental pain and distress, relational and functional difficulties (including fatigue), and maladaptive cognitions. Each is followed by a consolidation session reviewing content and introducing open, centered, and engaged response styles through experiential exercises.
Receives: Behavioral: Acceptance and Commitment Therapy (ACT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EQ-5D-5L

    The primary outcome will be health-related quality of life, assessed using the EQ-5D-5L (health states range from 11111, representing the best health state, to 55555, representing the worst health state).

    Measured: change from baseline to 6-month follow up

Secondary outcomes (25)
  1. Endometriosis Health Profile Questionnaire (EHP-5)

    Endometriosis Health Profile Questionnaire (EHP-5), with higher scores indicating worse endometriosis-related quality of life.

    Measured: change from baseline to 6-month follow up

  2. Brief Pain Inventory - Short Form (BPI-SF)

    Brief Pain Inventory - Short Form (BPI-SF), with higher scores indicating greater pain-related disability.

    Measured: change from baseline to 6-month follow up

  3. Psychological Pain Index (PPI)

    Psychological Pain Index (PPI), with higher scores indicating greater psychological pain.

    Measured: change from baseline to 6-month follow up

  4. Symptom Questionnaire (SQ)

    Symptom Questionnaire (SQ), with higher scores indicating greater psychological distress.

    Measured: change from baseline to 6-month follow up

  5. Somatic Symptom Disorder - B Criteria Scale (SSD-12)

    Somatic Symptom Disorder - B Criteria Scale (SSD-12), with higher scores indicating greater somatic symptom burden.

    Measured: change from baseline to 6-month follow up

  6. Pain Catastrophizing Scale (PCS)

    Pain Catastrophizing Scale (PCS), with higher scores indicating greater pain catastrophizing.

    Measured: change from baseline to 6-month follow up

  7. Chronic Pain Acceptance Questionnaire (CPAQ)

    Chronic Pain Acceptance Questionnaire (CPAQ), with higher scores indicating greater pain acceptance.

    Measured: change from baseline to 6-month follow up

  8. Multidimensional Psychological Flexibility Inventory (MPFI)

    Multidimensional Psychological Flexibility Inventory (MPFI), with higher scores indicating greater psychological flexibility/inflexibility.

    Measured: change from baseline to 6-month follow up

  9. Acceptance and Action Questionnaire - II (AAQ-II)

    Acceptance and Action Questionnaire - II (AAQ-II), with higher scores indicating greater psychological inflexibility.

    Measured: change from baseline to 6-month follow up

  10. Cognitive Fusion Questionnaire (CFQ)

    Cognitive Fusion Questionnaire (CFQ), with higher scores indicating greater cognitive fusion.

    Measured: change from baseline to 6-month follow up

  11. Cognitive Emotion Regulation Questionnaire (CERQ)

    Cognitive Emotion Regulation Questionnaire (CERQ), with higher scores indicating greater use of that specific emotion regulation strategy.

    Measured: change from baseline to 6-month follow up

  12. Satisfaction with Life Scale (SWLS)

    Satisfaction with Life Scale (SWLS), with higher scores indicating greater life satisfaction.

    Measured: change from baseline to 6-month follow up

  13. World Health Organization-Five Well-Being Index (WHO-5)

    World Health Organization-Five Well-Being Index (WHO-5), with higher scores indicating greater psychological well-being.

    Measured: change from baseline to 6-month follow up

  14. Illness Attitudes Scale (IAS)

    Illness Attitudes Scale (IAS), with higher scores indicating more dysfunctional illness-related attitudes.

    Measured: change from baseline to 6-month follow up

  15. Brief Illness Perception Questionnaire (BIPQ)

    Brief Illness Perception Questionnaire (BIPQ), with higher scores indicating more negative illness perceptions.

    Measured: change from baseline to 6-month follow up

  16. Female Sexual Function Index (FSFI)

    Female Sexual Function Index (FSFI), with higher scores indicating better sexual functioning.

    Measured: change from baseline to 6-month follow up

  17. Chalder Fatigue Scale (CFS)

    Chalder Fatigue Scale (CFS), with higher scores indicating greater fatigue.

    Measured: change from baseline to 6-month follow up

  18. Fatigue Severity Scale (FSS)

    Fatigue Severity Scale (FSS), with higher scores indicating greater fatigue severity.

    Measured: change from baseline to 6-month follow up

  19. Beck Hopelessness Scale (BHS)

    Beck Hopelessness Scale (BHS), with higher scores indicating greater hopelessness.

    Measured: change from baseline to 6-month follow up

  20. Demoralization Scale (Psychiatric Epidemiology Research Interview - PERI)

    Demoralization Scale (Psychiatric Epidemiology Research Interview - PERI), with higher scores indicating greater demoralization.

    Measured: change from baseline to 6-month follow up

  21. Frost Multidimensional Perfectionism Scale (FMPS)

    Frost Multidimensional Perfectionism Scale (FMPS), with higher scores indicating higher levels of perfectionism.

    Measured: change from baseline to 6-month follow up

  22. Somatosensory Amplification Scale (SSAS)

    Somatosensory Amplification Scale (SSAS), with higher scores indicating greater somatic amplification.

    Measured: change from baseline to 6-month follow up

  23. Eating Disorder Inventory (EDI)

    Eating Disorder Inventory (EDI), with higher scores indicating greater eating-related psychopathology.

    Measured: change from baseline to 6-month follow up

  24. Childhood Trauma Questionnaire - Short Form (CTQ-SF)

    Childhood Trauma Questionnaire - Short Form (CTQ-SF), with higher scores indicating greater exposure to childhood trauma.

    Measured: change from baseline to 6-month follow up

  25. Social Readjustment Rating Scale (SRRS)

    Social Readjustment Rating Scale (SRRS), with higher scores indicating greater exposure to stressful life events.

    Measured: change from baseline to 6-month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2026
  2. Study start1 Jan 2027 (estimated)
  3. Primary completion30 Sep 2028 (estimated)
  4. Study completion31 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomized (1:1) controlled trial comparing CBT-based versus ACT-based psychotherapeutic interventions in women with endometriosis and/or adenomyosis. During the screening phase, eligibility will be assessed based on the study's inclusion and exclusion criteria. At baseline, sociodemographic and clinical variables (including age, marital status, education, employment status, anthropometric data, reproductive history, endometriosis/adenomyosis characteristics, symptom history, previous treatments, and pain-related clinical features), as well as psychological status, will be assessed. Participants will then be randomly assigned to either the CBT-based or ACT-based intervention. Assessments will be repeated after Session 4 (mid-intervention assessment), after Session 8 (post-intervention assessment), and at the 3- and 6-month follow-ups.
Masking
Single blind
Who is masked
Participant
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07907848
Sponsor's protocol ID
T-ENDO
Acronym
T-ENDO
Status last verified
Oct 2026
First submitted
24 Oct 2026
Last updated
4 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be shared upon request to the PI. Data can be shared as aggregated, anonymized information.

Publications

  • Geller S, Levy S, Ashkeloni S, Roeh B, Sbiet E, Avitsur R. Predictors of Psychological Distress in Women with Endometriosis: The Role of Multimorbidity, Body Image, and Self-Criticism. Int J Environ Res Public Health. 2021 Mar 26;18(7):3453. doi: 10.3390/ijerph18073453.

    PubMed 33810403
  • Donatti L, Malvezzi H, Azevedo BC, Baracat EC, Podgaec S. Cognitive Behavioral Therapy in Endometriosis, Psychological Based Intervention: A Systematic Review. Rev Bras Ginecol Obstet. 2022 Mar;44(3):295-303. doi: 10.1055/s-0042-1742406. Epub 2022 May 16.

    PubMed 35576938
  • Evans S, Skvarc D, Esterman A, Mackay MI, O'Shea M, Van Niekerk L, Druitt ML, Tsaltas J, Knowles SR, Parigi E, Stanley K, Harris J, Barber M, Dober M, Dowding C, Mikocka-Walus A. Telehealth cognitive behavioural therapy improves health-related quality of life and pain in endometriosis: the Healing Pelvic Pain Intervention (HaPPI)-a randomized controlled trial. Hum Reprod Open. 2026 Jan 22;2026(1):hoag006. doi: 10.1093/hropen/hoag006. eCollection 2026.

    PubMed 41717450
  • Nakao M, Shirotsuki K, Sugaya N. Cognitive-behavioral therapy for management of mental health and stress-related disorders: Recent advances in techniques and technologies. Biopsychosoc Med. 2021 Oct 3;15(1):16. doi: 10.1186/s13030-021-00219-w.

    PubMed 34602086
  • Del Pino-Sedeno T, Cabrera-Maroto M, Abrante-Luis A, Gonzalez-Hernandez Y, Ortiz Herrera MC. Effectiveness of psychological interventions in endometriosis: a systematic review with meta-analysis. Front Psychol. 2024 Oct 28;15:1457842. doi: 10.3389/fpsyg.2024.1457842. eCollection 2024.

    PubMed 39529727
  • World Health Organization. (2019). International statistical classification of diseases and related health problems (11th ed.). https://icd.who.int/

  • First, M. B., Williams, J. B. W., Karg, R. S., & Spitzer, R. L. (2016). Structured clinical interview for DSM-5 disorders, clinician version (SCID-5-CV). American Psychiatric Association Publishing.

  • Alizadeh, P., Kooshki, S., & Tarvirdizadeh, H. (2024). The effectiveness of cognitive-behavioral therapy on pain intensity, childhood trauma, perfectionism, and psychological flexibility in patients with chronic pain. Health Nexus, 2(3), 8-17. https://doi.org/10.61838/kman.hn.2.3.2

  • Yu L, Scott W, McCracken LM. Change in fatigue in acceptance and commitment therapy-based treatment for chronic pain and its association with enhanced psychological flexibility. Eur J Pain. 2020 Jan;24(1):234-247. doi: 10.1002/ejp.1480. Epub 2019 Oct 13.

    PubMed 31487413
  • Sundstrom FTA, Lavefjord A, Buhrman M, McCracken LM. Associations between psychological flexibility and daily functioning in endometriosis-related pain. Scand J Pain. 2023 Oct 23;24(1). doi: 10.1515/sjpain-2022-0157. eCollection 2024 Jan 1.

    PubMed 37867345
  • Shih YH, Wang SJ, Fan CT, Lu TF, Chen YF, Sun L, Hsu ST, Tseng JJ, Lu CH. Long-term risk of psychiatric disorders in women with endometriosis: A retrospective cohort study. Compr Psychiatry. 2026 Jan;144:152649. doi: 10.1016/j.comppsych.2025.152649. Epub 2025 Nov 21.

    PubMed 41308609
  • Samami E, Shahhosseini Z, Khani S, Elyasi F. Pain-focused psychological interventions in women with endometriosis: A systematic review. Neuropsychopharmacol Rep. 2023 Sep;43(3):310-319. doi: 10.1002/npr2.12348. Epub 2023 Jun 27.

    PubMed 37366616
  • Rostvall M, Magnusson C, Gemzell-Danielsson K, Kosidou K, Sieurin J. Adverse childhood experiences and the risk of endometriosis-a nationwide cohort study. Hum Reprod. 2025 Sep 1;40(9):1735-1743. doi: 10.1093/humrep/deaf101.

    PubMed 40495636
  • Ramin-Wright A, Schwartz ASK, Geraedts K, Rauchfuss M, Wolfler MM, Haeberlin F, von Orelli S, Eberhard M, Imthurn B, Imesch P, Fink D, Leeners B. Fatigue - a symptom in endometriosis. Hum Reprod. 2018 Aug 1;33(8):1459-1465. doi: 10.1093/humrep/dey115.

    PubMed 29947766
  • Pontoppidan K, Olovsson M, Grundstrom H. Clinical factors associated with quality of life among women with endometriosis: a cross-sectional study. BMC Womens Health. 2023 Oct 24;23(1):551. doi: 10.1186/s12905-023-02694-5.

    PubMed 37875883

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) in people with Endometriosis and Adenomyosis, run by Fiammetta Cosci at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fiammetta Cosci (0552755066, fiammetta.cosci@unifi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EQ-5D-5L (time frame: change from baseline to 6-month follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07907848, which also lists 33 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in